Phil Morle
Partner @ Main Sequence Ventures
Sydney, Australia
Phil Morle is a Series A investor at Main Sequence Ventures in Sydney focused on Food Processing and Software. Co-Founder & CEO of Pollenizer. Board Member and Incubation designer at Ideabox. Startup founder of over 35 companies.Phil co-founded Pollenizer in 2008 to help startup entrepreneurs get started with their dreams. He has led the development of Pollenizer’s internal practice for repeatedly launching new ideas into markets. He is one of theworld’s well-known lean startup practitioners, training and advising thousands of entrepreneurs as well as intrapreneurs in large companies across Asia Pacific.Before Pollenizer, he was the CTO at Kazaa for 5 years and led the development of a technology strategy which saw 5 million users online at any one time, millions of downloads per day and a total global user base of over 100 million, all this powered by innovative technology, a globally distributed team and a sprinkling of imagination.Before that, strangely, Phil was a theatre director with companies in the UK and Australia. This taught him the discipline of making something valuable with few resources.Phil was Founder Institute Mentor of the Year in 2013 and listed as one of Sydney’s most influential people by the Sydney Morning Herald in 2011.
- Total investments:
- 20
- Last investment:
- Lead investor:
- 40%
Last updated:
For AI agents: llms.txt
Industries Phil Morle invests in
Stages Phil Morle invests in
Countries Phil Morle invests in
Investment Focus
Industry
- Food Processing 3 (15%)
- Software 2 (10%)
- Recycling 2 (10%)
- Sustainability 2 (10%)
- Food and Beverage 2 (10%)
Stage
- Series A 7 (35%)
- Seed 5 (25%)
- Series B 2 (10%)
- Pre-Seed 1 (5%)
- Series D 1 (5%)
Country
- Australia 8 (40%)
- United States 1 (5%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Cauldron Ferm
|
Cauldron Ferm is a bio-acceleration process that exponentially scales up any precision fermented prototype to commercial quantities faster and with a lower cost of goods than any traditional production method. | $13.3M / Series A / Mar 24, 2026 | |
The EVERY Company
|
Clara Foods™ is the market leader in engineering, manufacturing and formulating animal-free, animal proteins as ingredients for the global food and beverage industry. Leveraging advanced fermentation to produce functional and nutritional proteins from microorganisms, the Company is reimagining the factory farm model that underpins industrial animalagriculture with a more sustainable, kinder and healthier alternative. Clara Foods is on a mission to decouple the world's most powerful proteins from the animals that make them. | $55M / Series D / Nov 04, 2025 | |
ULUU
|
ULUU is an ocean material that replaces plastic and actively benefits the world. | $10.5M / Series A / Oct 29, 2025 | |
Q-CTRL
|
Q-CTRL is a global pioneer with unmatched commercial traction in the emerging quantum technology industry - a sector poised to transform everything from finance and pharma through to logistics and defense.Q-CTRL is a category defining business leading the development of AI-powered quantum infrastructure software, delivering globally uniquetechnology to accelerate the pathway to the world's first useful quantum computers. This same foundational technology also underpins Q-CTRL’s development of novel “software-defined” quantum sensors for defense and intelligence.Q-CTRL has assembled the world’s foremost team of expert quantum-control engineers, providing solutions to global quantum technology leaders including Universities, National Labs, and quantum technology industry partners. In May 2023, IBM Quantum announced that Q-CTRL's quantum infrastructure software would be natively embedded in its quantum computing fleet, and the team recently announced a partnership with Transport for NSW - delivering its enterprise infrastructure software to transport data scientists exploring quantum computing. In parallel, in July 2023 the Australian Department of Defence announced Q-CTRL's leading role delivering quantum-assured navigation to AUKUS allies.Q-CTRL is a World Economic Forum Global Innovator, and is a member of the Quantum Economic Development Consortium, US Geospatial Intelligence Foundation, and a co-chair of the Australian Quantum Alliance within the Tech Council of Australia. Q-CTRL was selected as a Gartner Cool Vendor for 2023, one of the Top 10 Most Innovative Tech Companies by the Financial Review, and has been featured in The New York Times, The Economist, Forbes, Wired, Gizmodo, and more. | $59M / Series B / Oct 08, 2024 | |
Samsara Eco
|
Samsara Eco is an enviro-tech company creating infinite recycling to end plastic pollution. | $66.5M / Series A / Jun 26, 2024 | |
|
Cauldron Ferm
|
Cauldron Ferm is a bio-acceleration process that exponentially scales up any precision fermented prototype to commercial quantities faster and with a lower cost of goods than any traditional production method. | $6.2M / Series A / Mar 18, 2024 | |
Eden Brew
|
Eden Brew is a food and beverage company providing a range of animal-free and precision-fermented milk and dairy products. | $15.4M / Series A / Oct 03, 2023 | |
|
Cauldron Ferm
|
Cauldron Ferm is a bio-acceleration process that exponentially scales up any precision fermented prototype to commercial quantities faster and with a lower cost of goods than any traditional production method. | $7M / Seed / Mar 28, 2023 | |
Rainstick
|
Rainstick a revolutionary indigenous Australian firm integrating traditional knowledge with current plant and fungal technology. | $120K / Pre-Seed / Mar 15, 2023 | |
|
ULUU
|
ULUU is an ocean material that replaces plastic and actively benefits the world. | $5.4M / Seed / Nov 15, 2022 | |
| See all 20 investments → | |||
Co-Investors
Horizons Ventures
9 deals together
SOSV
4 deals together
DCVC
3 deals together
Digitalis Ventures
3 deals together
HSG
3 deals together
ABC World Asia
2 deals together
About Main Sequence Ventures
Main Sequence Ventures invests in ambitious founders creating the next set of global industries leveraging deep tech or frontier technologies. The firm is backed by the Australian National Science Agency, CSIRO, the Australian Federal Government, and private investors. All Main Sequence investments leverage world-leading research from Australianpublic research organizations such as CSIRO, any of Australia's 41 universities or its multitude of other industry research agencies.
Main Sequence Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Mike Zimmerman
Partner
|
|||
|
Phil Morle
Partner
|
|||
Alezeia Brown
Investment Manager
|
|||
Bill Bartee
Partner
|
|||
Jun Qu
Deep tech VC
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Phil Morle invest in?
Phil Morle invests primarily in Food Processing, Software and Recycling startups, most often at Series A and Seed stage. Most of the 20 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Phil Morle last invest?
The most recent investment recorded for Phil Morle closed in Mar 2026. Shizune tracks 20 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
